Charlotte, NC
High Cholesterol Clinical Trials
Looking for paid clinical trials for high cholesterol or dyslipidemia near Charlotte NC? Right now, 5 studies are enrolling across 12 research sites. You may be compensated for your time, and no insurance is needed.
Tether is a nonprofit directory. Basically, we do not run studies. Besides, we are not paid to refer you.
5
Active Studies
12
Research Sites
+/- $100
Per Visit
New here? Read how this page works
Every study below is open near Charlotte right now. Each card tells you what the study is testing, who it is looking for, and what it pays. So here is the simplest way to work through them.
- Read the study cards below. Each one is a real study, and each one is enrolling today.
- Open “Who it's for, and what to expect.” Inside, you will find the rules for joining. Also, you will see how often you would visit and what happens at each visit.
- Tap “Check eligibility” on the study that fits you best. Not sure which one? Then use the button at the top of the page instead, and we will check you against all 5 at once.
- We send you your results. Along with them, you get the name and number of the clinic running each study you may fit. Finally, you call the clinic yourself if you want to join.
Of course, checking never signs you up for anything. You are only seeing where you might fit.
The 5 Studies Enrolling Near Charlotte Right Now
Every one of them is open today. So check your eligibility, or read the full record on ClinicalTrials.gov.

Olpasiran for Lp(a) (OCEAN(a) Prevention)
Amgen / Drug
Lipoprotein(a), or Lp(a), is a cholesterol particle that runs in families. Diet, exercise, and statins barely move it. Olpasiran is a shot given once every few months that switches off your body’s production of Lp(a). This study is for people with high Lp(a) who have never had a heart attack or stroke. The question it is asking: can lowering Lp(a) prevent that first event from ever happening?
Why researchers are excited: this is one of the first medicines ever built to lower Lp(a), a type of cholesterol that no approved drug can touch today.
Est. $1,200+ total
Check eligibility →Who it's for, and what to expect
Who this study is looking for
- Adults with high Lp(a), a free blood test at screening checks your level
- Never had a heart attack or stroke
- Extra heart risk factors like high blood pressure, diabetes, or a strong family history
- Comfortable getting an injection every few months
Probably not a fit if: you have already had a heart attack or stroke, the muvalaplin study below may fit instead.
- Placebo group: About half of people get a placebo. In fact, neither you nor the study doctor knows which group you land in. But you stay on your regular medicines either way.
- How long: Several years. It is a long-term prevention study, so the pay keeps coming the whole time.
- Clinic visits: About every 3 months, for the shot and a check-in.
- Phone calls: Also, short check-in calls between visits.
- Most invasive part: Blood draws, plus a shot under the skin. But no surgery and no overnight stays.
- What experts say:
- “It's a very exciting approach. It's a very select approach.” Robert Rosenson, MD, Icahn School of Medicine at Mount Sinai (TCTMD)
- “What are the long-term consequences of essentially silencing it by reducing its levels by more than 90%?” Stephen Nicholls, MBBS, PhD, Monash University (TCTMD)
- Full study record: View on ClinicalTrials.gov →

Muvalaplin Daily Pill (ACCLAIM-Lp(a))
Eli Lilly / Drug
Muvalaplin is the first once-a-day pill designed to lower Lp(a). Every other Lp(a) treatment in development is an injection, so a pill is a big deal for people who hate needles. This large study is for adults with elevated Lp(a) who have already had a heart attack, stroke, or artery blockage, or who are at high risk for a first one. You keep taking your regular cholesterol medications the whole time.
Why researchers are excited: it would be the first Lp(a) treatment you could take as a simple daily pill.
Est. $1,200+ total
Check eligibility →Who it's for, and what to expect
Who this study is looking for
- Adults with high Lp(a)
- Already had a heart attack, stroke, or blocked artery, or at high risk of a first one
- On stable cholesterol treatment
- Able to take one pill every day
Probably not a fit if: you cannot take a daily pill on schedule, or you are already in another Lp(a) study.
- Placebo group: About half get a placebo pill. But you keep taking your regular cholesterol medicine either way. So you are never left untreated.
- How long: Several years, because the study follows your heart health long-term.
- Clinic visits: Every few months, for labs and a check-in.
- Phone calls: Also, brief check-in calls between clinic visits.
- Most invasive part: Routine blood draws. But no shots and no procedures.
- What experts say:
- “We were encouraged by the degree of Lp(a) lowering in these patients who are most likely to benefit from its use and by the safety and tolerability.” Stephen Nicholls, MBBS, PhD, Victorian Heart Institute, Monash University (American Heart Association)
- “While muvalaplin appears to be an effective approach to lowering Lp(a) levels, we still need to study whether Lp(a) lowering will result in fewer heart attacks and strokes.” Stephen Nicholls, MBBS, PhD (American Heart Association)
- Full study record: View on ClinicalTrials.gov →

Enlicitide Oral PCSK9 Combo (MK-7262)
Merck / Drug
PCSK9 blockers are some of the strongest cholesterol-lowering drugs available, but until now they have only come as injections. Enlicitide is a pill version. This study tests it alongside MK-7262, a second pill aimed at Lp(a), in adults with elevated Lp(a). It is a shorter commitment than the big outcome trials, and it is testing two of the newest oral cholesterol drugs in one protocol.
Why researchers are excited: it could turn one of the strongest injectable cholesterol treatments into an everyday pill.
Est. $1,000 to $1,400
Check eligibility →Who it's for, and what to expect
Who this study is looking for
- Adults with elevated Lp(a)
- Willing to take daily study pills
- Okay with lab visits more often than a normal checkup, especially early on
Probably not a fit if: you had a heart attack or stroke very recently, the clinic confirms the exact timing rules.
- Placebo group: Some people get placebo versions of one or both pills. But the clinic tells you the odds before you agree.
- How long: About 12 to 16 months.
- Clinic visits: Every 4 to 8 weeks at first. Then they spread further apart.
- Phone calls: Also, a few calls to check on side effects.
- Most invasive part: Blood draws at most visits. But no shots and no procedures.
- What experts say:
- “Anecdotally, there are a number of patients who would prefer an oral to an injectable therapy.” Ann Marie Navar, MD, UT Southwestern Medical Center (TCTMD)
- “A large cardiovascular outcomes study will be needed to determine if the oral agent reduces hard clinical events.” Donald Lloyd-Jones, MD, Boston University School of Medicine (TCTMD)
- Full study record: View on ClinicalTrials.gov →

VERVE-102 One-Time Gene Editing
Verve Therapeutics / Drug
This is the most futuristic study on this page. VERVE-102 is a single IV infusion that edits the PCSK9 gene in your liver, with the goal of turning down LDL cholesterol permanently. One treatment instead of daily pills for life. It is an early-phase study for adults with inherited high cholesterol (familial hypercholesterolemia) or heart disease that showed up unusually young.
Why researchers are excited: a single infusion could one day replace a lifetime of daily cholesterol pills.
Est. $1,200+ total
Check eligibility →Who it's for, and what to expect
Who this study is looking for
- Adults with inherited high cholesterol (familial hypercholesterolemia) or heart disease that showed up unusually young
- LDL still high even on treatment
- Comfortable with a one-time IV infusion and close follow-up afterward
Probably not a fit if: you do not have inherited high cholesterol and your LDL is controlled on your current medication.
- Placebo group: No placebo. So everyone in this study gets the real treatment.
- How long: About a year of close follow-up. Then longer check-ins after that.
- Clinic visits: Often in the first few months after the infusion. Then they taper off.
- Phone calls: Also, regular safety calls, especially early on.
- Most invasive part: One IV infusion, plus blood draws. Gene editing is permanent. So the team walks you through exactly what that means before you decide.
- What experts say:
- “We'll be doing phase II and a broader development program to really capture that long-term safety data.” Scott Vafai, MD, chief medical officer, Verve Therapeutics (TCTMD)
- “That's the main concern: you're going to inadvertently edit something that you didn't want to edit.” Daniel Soffer, MD, University of Pennsylvania, National Lipid Association (TCTMD)
- Full study record: View on ClinicalTrials.gov →

Healthy Living Anson (Lifestyle Study)
UNC Chapel Hill / Lifestyle
Not a drug trial. This UNC study is for adults in Anson County, about an hour east of Charlotte, living with high cholesterol, high blood pressure, diabetes, or extra weight. One group gets nutrition education plus healthy food delivered to their home. The other gets a physical activity program. No pills, no injections, no placebo. Just a real test of whether food and movement support can move the numbers.
Why researchers are excited: it tests whether food support at home can move cholesterol numbers as well as an exercise program does.
Est. $400 to $600
Check eligibility →Who it's for, and what to expect
Who this study is looking for
- Adults living in Anson County (Wadesboro area, about an hour east of Charlotte)
- Living with high cholesterol, high blood pressure, diabetes, or extra weight
- Interested in food support or an activity program
Probably not a fit if: you live outside Anson County.
- Placebo group: No placebo. So everyone gets one of two real programs: food lessons with home delivery, or an exercise plan.
- How long: Several months of support, plus check-ins along the way.
- Clinic visits: Just a handful of check-ins, and mostly local.
- Phone calls: Also, regular support calls.
- Most invasive part: Basic measurements, plus a blood draw to track your numbers.
- Full study record: View on ClinicalTrials.gov →
Not sure which one fits you?
First, answer a few quick health questions. Then we check your answers against all 5 studies for you. No account, no paperwork.
See if I may fit one of these studies →High Cholesterol Trials in Charlotte NC. Here Is What Is Changing.
Statins Only Fix Half the Problem
To begin with, one drug ruled high cholesterol for thirty years: the statin. Statins lower LDL, the “bad” cholesterol. Also, they work well for most people. But they do almost nothing for a second troublemaker. In fact, your doctor may have never measured it. It is called lipoprotein(a), or Lp(a) for short. In fact, about one in five people has too much of it. Your genes set that level, so diet, exercise, and statins barely move it.
That Is Finally Changing
That is exactly what is changing. Right now, the studies near Charlotte are testing the first drugs ever built to lower Lp(a). Two of them are huge Phase 3 trials. One comes from Amgen. The other comes from Eli Lilly. On top of that, both are enrolling here in the Carolinas. So if you want paid clinical trials for high cholesterol near Charlotte NC, this is the moment.
Overall, 5 cholesterol and dyslipidemia studies are enrolling in and around Charlotte. First, one is a shot you get every few months. Another is a pill you take each morning. A third is a single gene editing infusion. Also, one simply sends healthy food to your door. Altogether, pay runs from a few hundred dollars up to $3,000 or more. Also, none of them require insurance.
New to clinical trials? Start with our Clinical Trials 101 guide →The New Wave of Cholesterol Research Near Charlotte
Three of these studies stand out. That is because none of them work like a statin does.
Olpasiran: One Shot, Every Few Months
First, olpasiran from Amgen shuts the problem off at the source. Generally, most drugs block Lp(a) after your body makes it. This one works a step earlier. In short, it tells your liver to stop making Lp(a) at all. Also, one shot lasts for months. Notably, the OCEAN(a) trial is unusual for another reason too. Most heart studies wait until you have already had a heart attack. But this one enrolls people who never have. In other words, it is trying to get there first.
Muvalaplin: The Pill You Take With Breakfast
Next, muvalaplin from Eli Lilly does the same job as a pill. Specifically, it stops the two halves of the Lp(a) particle from snapping together. So if you would rather take a tablet with breakfast than get a shot at a clinic, this trial was built for you. Merck is trying something similar with enlicitide. Likewise, that pill does the work of the injectable PCSK9 drugs.
VERVE-102: One Infusion, Then You Are Done
Finally, VERVE-102 is the boldest of the three. Basically, it uses base editing, a very precise form of CRISPR. Then, in one infusion, it switches off the PCSK9 gene in your liver. The idea is simple: one treatment, once, instead of pills for life. For now, it is only open to people with inherited high cholesterol. Even so, it could change cholesterol care for everyone.
High Cholesterol Help Near Charlotte NC
Generally, most people expect two choices: a prescription, or changes they make on their own. But there is a third one, and it rarely comes up. That third choice is research. Specifically, a study gives you regular lab work, EKGs, and check-ins with a trained team. All of it costs nothing. Besides, your own doctor still runs your care.
Why People Join, Even When They Feel Fine
To be clear, a study does not replace your doctor. In fact, Tether is a directory, not a clinic. Even so, help can be hard to find between appointments, especially without good insurance. So research fills that gap for a lot of people. Someone checks your numbers on a set schedule. Someone calls when a result looks off. Also, you get paid for your time along the way.
Best Sites for Cholesterol Trials Near Charlotte NC
Generally, cholesterol and heart studies are bread and butter for Charlotte sites. They need lab work, EKGs, and steady follow-up. But they do not need rare equipment. So plenty of sites here handle them well.
The Big Hospital Systems
First, Atrium Health is the anchor for heart research near Charlotte NC. It runs 161+ active studies. It is tied to Wake Forest University School of Medicine. On top of that, it houses the Sanger Heart & Vascular Institute. As a result, the big multi-year heart trials tend to land there first.
Meanwhile, Novant Health is the other heavyweight. Likewise, its Heart & Vascular Institute runs heart, weight, and blood pressure studies. It does so across several Charlotte locations. So cholesterol trials sit right in its wheelhouse.
The Independent Sites
Finally, Monroe Biomedical Research is the standout independent site. In fact, it ranks among the 5 highest-enrolling research sites in the country. Specifically, it focuses on the exact mix these trials draw from: blood pressure, weight, and heart risk. So if a new cholesterol trial opens near Charlotte, Monroe is a likely home for it.
Not all of them run cholesterol studies today. But sites add new studies all the time. So it is worth knowing what sits near you.

Atrium Health
Multiple Charlotte locations / 161+ active studies
Crohn’s, Heart Failure, COPD, Dementia, Type 2 Diabetes, Hypertension
Charlotte’s biggest health system. It is tied to Wake Forest University School of Medicine. Also, it runs far more trials than anyone else nearby.
Visit Website →
American Health Research Network
Ballantyne, NC 28277 / 25 to 30+ active studies
Asthma, COPD, Chronic Cough, Type 2 Diabetes
Led by Dr. Selwyn Spangenthal. It is the biggest private lung research group in Charlotte. Specifically, it has 4 offices: Charlotte, Rock Hill, Lake Norman, and Charleston.
Visit Website →
Monroe Biomedical Research
Monroe, NC / 17+ active studies
Asthma, COPD, Hypertension, Obesity, Ulcerative Colitis
Notably, one of the 5 busiest research sites in the country. Its 6,300 sq ft space can host overnight stays. It is also an SCRS Global Impact Partner.
Visit Website →
Clinical Research of Gastonia
Gastonia, NC / 11+ active studies
Asthma, COPD, Chronic Cough, Idiopathic Hypersomnia
Led by Dr. Anup Banerjee. Its 3,500 sq ft space sits next to CaroMont Regional Medical Center. Also, it has been running for over 10 years.
Visit Website →
OnSite Clinical Solutions
Ballantyne, NC 28277 / 10+ active studies
Ulcerative Colitis, Crohn’s, COPD, Heart Failure, Atopic Dermatitis
It works with Charlotte doctors in heart, gut, skin, nerve, and joint care. Besides, it runs studies from Phase I through Phase IV.
Visit Website →
Flourish Research
Matthews, NC 28105 / 4+ active studies
Alzheimer’s Disease, Early Alzheimer’s, Alzheimer’s-Related Psychosis
Led by Dr. M. Reza Bolouri. He has 20+ years in Alzheimer’s research. The site is an Alzheimer’s Center of Excellence. In fact, its network has finished 5,500+ trials.
Visit Website →
New Hope Clinical Research
SouthPark, NC 28211 / 4+ active studies
Major Depression, Schizophrenia, Bipolar Disorder
Led by Dr. Kurian Abraham. It runs Phase I through IV studies and has 30 beds for overnight stays. Its last FDA audit came back clean. Also, it has finished 200+ brain studies.
Visit Website →
Queen City Clinical Research
SouthPark, NC 28211 / 2+ active studies
Chronic Pain, Chronic Migraine, Osteoarthritis
Led by Dr. Leonardo Kapural, a former Cleveland Clinic professor. Notably, he has written 200+ journal articles. On top of that, many call this the biggest pain research site in the country.
Visit Website →
Novant Health
Multiple Charlotte locations / Several active studies
Cardiovascular Disease, Obesity, Hypertension
One of the biggest health systems in the Carolinas. Its Heart and Vascular Institute runs heart studies and sees a lot of patients.
Visit Website →
DLVSC
4 Charlotte-area offices / 1+ active studies
Eczema, Psoriasis, Rosacea
Led by Dr. Gilly Munavalli. This award-winning skin practice owns 50+ FDA-approved lasers and devices. Also, it has its own research team.
Visit Website →
DelRicht Research
South Charlotte, NC 28210 / 1+ active studies
Bipolar Disorder, Bipolar Depression
Part of a national network of mental health research sites. Currently, it runs the azetukalner bipolar depression trial in Charlotte. Previously, it ran other mental health studies.
Visit Website →
TMS of the Carolinas
South Charlotte, NC 28210 / 1+ active studies
Major Depression, Treatment-Resistant Depression
A specialty site for brain stimulation care. It runs the fast TMS study that packs 6 weeks into 2.
Visit Website →What to Expect in a Cholesterol Trial
New to studies? Here is how one works, step by step.
01
Prescreening
First comes a short phone call or online form. It takes about 10 to 15 minutes. The staff check if you might qualify. Then, if you do, they book your first visit.
02
Screening Visit
Next, you go in person for lab work and a health history. For cholesterol studies, that means a blood draw. It checks your LDL and your Lp(a). This visit is almost always free.
03
Treatment Period
Then come regular visits, over months or even years. You get the study drug or a placebo. Also, the team checks on you the whole way through.
04
Follow-Up
Finally, a few last visits after treatment ends. The team makes sure you are doing well. Besides, you can stop at any time, for any reason.
High Cholesterol Clinical Trial FAQs
Real answers about high cholesterol clinical trials in Charlotte NC.
How much do high cholesterol clinical trials pay in Charlotte?
Overall, it depends on the study. Lifestyle studies like Healthy Living Anson pay less cash. But they add real perks, like free food delivery. The drug trials pay you per visit. In fact, because the Lp(a) studies run for years, the total can reach $3,000 or more. You get paid as you go, not in one lump sum at the end.
Will I have to stop my statin?
Almost never. The Lp(a) trials are add-on studies. That means you stay on your statin, and the study drug goes on top. In fact, most of them want you on steady treatment already. Also, the team walks you through what changes before you agree to anything.
What is Lp(a) and why is every trial about it?
Basically, lipoprotein(a) is a cholesterol particle your liver makes. Your genes decide how much. In fact, about 1 in 5 people has a high level. On top of that, it raises the risk of heart attack and stroke on its own, even when the rest of your cholesterol looks fine. So far, no approved drug lowers it. That is why every big drug company is racing to be first. Of course, a simple blood test tells you your level, and the trials run it free at screening. In fact, many people learn their number for the first time through a study.
I feel fine. Why would I join a cholesterol trial?
Notably, high cholesterol has no symptoms. That is what makes it dangerous. Also, it is also what makes these trials different. Specifically, the olpasiran study wants people who feel fine and have never had a heart event. In return, you get years of free lab work, EKGs, and heart monitoring. That care would cost thousands. Plus you get paid for your time.
Do I need health insurance to participate?
No. Regardless of your insurance, all study care and study medicine is free. In fact, many people join for that reason. A study opens the door to specialist care and new treatments they could not otherwise afford.
How long do cholesterol clinical trials last?
Longer than most. Specifically, the Merck enlicitide study runs about a year. But the two big Lp(a) trials follow people for several years. That is because they measure whether heart attacks and strokes actually drop, not just whether a lab number moves. A long trial has an upside, though. Overall, you get steady pay, plus years of close heart monitoring at no cost. Also, you can stop at any time.
Will I get a placebo?
In three of them, yes. Some people get a placebo in the olpasiran, muvalaplin, and enlicitide trials. Neither you nor your study doctor knows which group you land in. But everyone stays on their regular cholesterol medicine either way. So you are never left untreated. The VERVE-102 and Healthy Living Anson studies have no placebo at all. Besides, the clinic tells you the exact odds before you agree to anything.
What is the newest treatment for high cholesterol?
The newest wave targets Lp(a), the inherited cholesterol that statins cannot lower. First, olpasiran is a shot you get every few months. Second, muvalaplin is a daily pill. Both are in late-stage trials, and both are enrolling near Charlotte. Behind them come PCSK9 pills like enlicitide, and even one-time gene editing. None of them are approved yet. In fact, that is exactly why the studies on this page exist.
Can a person with high cholesterol improve it without statins?
Sometimes. Basically, it depends on which kind of cholesterol you mean. Generally, diet, exercise, and weight loss can lower LDL a lot for many people. Also, non-statin medicines already exist. But Lp(a) does not budge for lifestyle changes or statins. That is exactly why these trials matter. Of course, this is general information, not medical advice. So talk with your doctor about your numbers.
Where can I get help with high cholesterol near Charlotte NC?
First, start with your regular doctor. They can check your numbers and prescribe treatment. After that, research is an overlooked source of support in the Charlotte area. Specifically, studies give you free lab work, regular monitoring, and early access to new treatments. On top of that, they pay you for your time. So if cost or insurance is in your way, a study can be a practical option. Finally, the ones on this page are enrolling now.
Ready to Explore a Study?
Check your eligibility, or just reach out to our Charlotte team. No pressure. Also, no sales pitch.
← Back to All Clinical TrialsSources
- Olpasiran OCEAN(a) Prevention study, ClinicalTrials.gov NCT07136012
- Muvalaplin ACCLAIM-Lp(a) study, ClinicalTrials.gov NCT07157774
- Enlicitide and MK-7262 study, ClinicalTrials.gov NCT07614984
- VERVE-102 study, ClinicalTrials.gov NCT06164730
- Healthy Living Anson study, ClinicalTrials.gov NCT07126587
- American Heart Association: Lipoprotein(a)
- TCTMD: Dramatic Reductions in Lp(a) With Olpasiran (OCEAN(a)-DOSE)
- American Heart Association newsroom: muvalaplin trial results
- TCTMD: Oral PCSK9 Inhibitor Enlicitide Cuts LDL Cholesterol (CORALreef Lipids)
- TCTMD: Gene-Editing Therapy Safely Lowers PCSK9, LDL Cholesterol (Heart-2)
- America's Health Rankings: High Cholesterol, North Carolina (2023 BRFSS)
- America's Health Rankings: Cardiovascular Diseases, North Carolina (2024 BRFSS)
- CDC: High Cholesterol Facts
Study details verified against ClinicalTrials.gov on August 10, 2026. Study availability and criteria change; the research clinic confirms everything before you enroll.